Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Clinical Chemistry and Laboratory Medicine, |
RCV002467396 | SCV002762659 | pathogenic | High molecular weight kininogen deficiency | 2022-12-06 | criteria provided, single submitter | clinical testing | Using medical exome sequencing (confirmation via Sanger sequencing), we identified this variant (NM_001102416.3(KNG1):c.1165C>T p.(Arg389*)) and the canonical splice site variant c.1038+1G>A in compound heterozygosity as the cause of high-molecular-weight kininogen (HK) deficiency in one individual (PMID: 32202057). This case was originally described as being prekallikrein (PK) deficient due to low PK activity (7%) (Tomao et al.; Biochim Clin.; 2015; 39:e7-e9). The HK deficiency could not be investigated on protein level because no patient plasma was available, but the patient was described as having a massively prolonged aPTT, and exome sequencing did not reveal any relevant variants in/around KLKB1. Therefore, the previously observed low PK level is most likely secondary to HK deficiency, as seen elsewere (Adenaeuer et al. PMID: ). The c.1165C>T variant results in a frameshift and, due to its position in exon 10a, in both HK and likely low-molecular-weight kininogen deficiency. In addition, the variant was also found to cause HK deficiency in another family unrelated to our case, also in compound heterozygosity (PMID: 31858768). We classified the variant as pathogenic (ACMG guideline). |